Wells Fargo
SQZ

Wells Fargo’s SQZ Biotechnologies Company SQZ Stock Holding History

Wells Fargo’s Portfolio SQZ Stock Details SQZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-140
Closed -$38 – 7807
2023
Q2 		$38 Buy
140
+6
+4% +$3 ﹤0.01% 7128
2023
Q1 		$75 Buy
134
+2
+2% +$1 ﹤0.01% 7004
2022
Q4 		$98 Buy
132
+4
+3% +$9 ﹤0.01% 6802
2022
Q3 		$0 Buy
128
+4
+3% +$12 ﹤0.01% 7726
2022
Q2 		$0 Sell
124
-21,278
-99% -$76.6K ﹤0.01% 7823
2022
Q1 		$103K Sell
21,402
-9,851
-32% -$62.5K ﹤0.01% 5319
2021
Q4 		$279K Sell
31,253
-22,238
-42% -$273K ﹤0.01% 5076
2021
Q3 		$772K Buy
53,491
+49,985
+1,426% +$677K ﹤0.01% 4409
2021
Q2 		$51K Sell
3,506
-629
-15% -$8.22K ﹤0.01% 5550
2021
Q1 		$56K Buy
4,135
+1,817
+78% +$36.9K ﹤0.01% 5763
2020
Q4 		$67K Buy
+2,318
New +$59.2K ﹤0.01% 5498

Other funds holding SQZ

AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
BSB
Bangor Savings Bank Bangor, Maine $1.36B AUM 19.29% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo's SQZ Position: Q3 2023 in Review

Wells Fargo sold out of SQZ Biotechnologies Company (SQZ) in Q3 2023, closing a stake of 140 shares — an estimated $38 sold.

Wells Fargo first reported a position in SQZ in Q4 2020 and held it in 11 quarters. The position peaked at $772K in Q3 2021. 5 funds tracked by Wall St. Rank hold SQZ as of Q3 2023.

  • Wells Fargo reported no remaining SQZ Biotechnologies Company position as of Q3 2023 after selling out during the quarter.
  • Wells Fargo sold 140 SQZ Biotechnologies Company shares in Q3 2023, an estimated $38.
  • Wells Fargo first reported a position in SQZ Biotechnologies Company in Q4 2020 and held it in 11 quarters.
  • Wells Fargo's SQZ Biotechnologies Company position peaked at $772K in Q3 2021.
  • 5 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q3 2023.

Based on Wells Fargo's 13F filing for Q3 2023, filed 13 Nov 2023.